Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Stingray Therapeutics, Inc. See All Filings	D	2024-05-14 13:17:02 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0001759143 Filed Document 0001759143-24-000002 Exclusions or Exemptions 506b Accepted Date 2024-05-14 13:17:02 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Stingray Therapeutics, Inc. See All Filings	D	2024-02-01 18:13:03 UTC
Amount To Be Raised $450,000 Associated Brokers / Dealers N/A CIK Number 0001759143 Filed Document 0001759143-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-02-01 18:13:03 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Stingray Therapeutics, Inc. See All Filings	D/A	2023-12-28 17:28:51 UTC
Amount To Be Raised $6,668,926 Associated Brokers / Dealers N/A CIK Number 0001759143 Filed Document 0001759143-23-000004 Exclusions or Exemptions 506b Accepted Date 2023-12-28 17:28:51 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Stingray Therapeutics, Inc. See All Filings	D	2023-03-31 12:21:12 UTC
Amount To Be Raised $5,230,297 Associated Brokers / Dealers N/A CIK Number 0001759143 Filed Document 0001759143-23-000001 Exclusions or Exemptions 506b Accepted Date 2023-03-31 12:21:12 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Equity
Stingray Therapeutics, Inc. See All Filings	D/A	2021-05-26 10:15:02 UTC
Amount To Be Raised $3,000,000 Associated Brokers / Dealers Scott Andrew Jordan and Liberi Life Sciences Consultancy BV CIK Number 0001759143 Filed Document 0001759143-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-05-26 10:15:02 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Debt
Stingray Therapeutics, Inc. See All Filings	D/A	2020-10-13 12:48:41 UTC
Amount To Be Raised $1,500,000 Associated Brokers / Dealers Scott Andrew Jordan and Liberi Life Sciences Consultancy BV CIK Number 0001759143 Filed Document 0001759143-20-000003 Exclusions or Exemptions 506c Accepted Date 2020-10-13 12:48:41 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Debt
Stingray Therapeutics, Inc. See All Filings	D	2020-08-13 08:52:15 UTC
Amount To Be Raised $1,500,000 Associated Brokers / Dealers Scott Andrew Jordan and Liberi Life Sciences Consultancy BV CIK Number 0001759143 Filed Document 0001759143-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-08-13 08:52:15 UTC Type of Offering D Industry Biotechnology Principal Place of Business TEXAS Revenue or Assets Decline to Disclose Type of Security Debt